Dr. Smilez Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.18 M
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.49 M
- Revenue Growth 32.01%
- Profit Growth 355.77%
- Ebitda 841.76%
- Net Worth 63.01%
- Total Assets -4.10%
About Dr. Smilez Healthcare
Dr. Smilez Healthcare Private Limited (DSHPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 February 2008 and has a history of 16 years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.18 M.
The company currently has active open charges totaling ₹0.49 M.
Rajarathinam Sivaprakash and Vallishanmugapriya serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85120TN2008PTC066412
-
Company No.
066412
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Feb 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Dr. Smilez Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajarathinam Sivaprakash
|
Director | 13-Feb-2008 | Current |
|
Vallishanmugapriya
|
Director | 28-Aug-2020 | Current |
Financial Performance of Dr. Smilez Healthcare.
Dr. Smilez Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.01% increase. The company also saw a substantial improvement in profitability, with a 355.77% increase in profit. The company's net worth Soared by an impressive increase of 63.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Smilez Healthcare?
In 2021, Dr. Smilez Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.49 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 May 2023 | Hdfc Bank Limited | ₹0.49 M | Open |
How Many Employees Work at Dr. Smilez Healthcare?
Dr. Smilez Healthcare has a workforce of 19 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Smilez Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Smilez Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
